DA32 Life Science Tech Acquisition Corp. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q3 2021 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
DA32 Life Science Tech Acquisition Corp. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q3 2021 to Q4 2022.
  • DA32 Life Science Tech Acquisition Corp. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $303K, a 152% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $303K +$183K +152% Dec 31, 2022 10-K 2023-03-29
Q4 2021 $120K Dec 31, 2021 10-K 2023-03-29
Q3 2021 $54K Sep 30, 2021 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.